Analyst Ratings for Halozyme Therapeutics (HALO)
HALO Rating Summary
HALO Price Target Summary
- Highest: $96.00 (TD Cowen)
- Lowest: $58.00 (Goldman Sachs)
- Average: $81.11
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$81.11 (+20.4%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 68%
Avg. $ Target:
$81.11 (+20.4%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 68%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/4/2025 | Goldman Sachs » Updated 1/29/2026 |
Corinne Jenkins | Downgrade | Sell (Neutral) |
58.00 (N/A) |
64.66 (67.37) |
4.19% | Details |
| 10/14/2025 | Leerink Partners | David Risinger | Upgrade | Market Perform (Underperform) |
70.00 (N/A) |
65.33 (67.37) |
3.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
